newsroompost
  • youtube
  • facebook
  • twitter
  1. Home

  2. Tag: Covaxin

Study shows Covaxin is safe & immunogenic in 2-18 volunteers: Bharat Biotech

Study shows Covaxin is safe & immunogenic in 2-18 volunteers: Bharat Biotech

 Newsroom Staff
Covaxin approved for kids above 12 years, DGCI gives nod to Bharat Biotech’s vaccine for emergency use

Covaxin approved for kids above 12 years, DGCI gives nod to Bharat Biotech’s vaccine for emergency use

 Newsroom Staff
Covaxin for 2-18 years: Centre examining Expert panel recommendations

Covaxin for 2-18 years: Centre examining Expert panel recommendations

 ANI
Covaxin 50 pc effective against symptomatic COVID: Lancet study

Covaxin 50 pc effective against symptomatic COVID: Lancet study

 ANI
Covaxin approved by UK and USA: Here is a look at countries you can visit after getting jabbed

Covaxin approved by UK and USA: Here is a look at countries you can visit after getting jabbed

 Bornika Das
On Diwali eve, WHO gives approval for emergency use of Covaxin, Made in India vaccine

On Diwali eve, WHO gives approval for emergency use of Covaxin, Made in India vaccine

 Newsroom Staff
Australia recognizes India’s Covaxin & China’s Sinopharm COVID-19 vaccine

Australia recognizes India’s Covaxin & China’s Sinopharm COVID-19 vaccine

 Newsroom Staff
Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data

Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data

 Newsroom Staff
WHO emergency use authorisation to Covaxin delayed till October 5

WHO emergency use authorisation to Covaxin delayed till October 5

 ANI
Mix of Covishield, Covaxin yields better results: ICMR Study

Mix of Covishield, Covaxin yields better results: ICMR Study

 ANI

What's New

Don't Miss

newsroompost

About Us

This site is run and owned by Headlong NewsroomPost India Private Limited.

Quick Link

 

Important Link

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited